Zartash Sial Paediatric Medicine

Zartash Sial Paediatric Medicine (operating as Zartash Sial Paeds Med) is a clinical research and healthcare entity based in Lahore, Pakistan, affiliated with King Edward Medical University. The organization specializes in neonatal medicine, with a primary focus on developing and evaluating prophylactic strategies for sepsis in preterm infants. Its lead research program investigates the use of enteral lactoferrin as an adjuvant therapy to reduce the incidence of clinical sepsis in vulnerable newborn populations. Through its clinical trials, the entity aims to provide evidence-based solutions to improve survival and health outcomes for premature babies. Zartash Sial Paediatric Medicine is actively involved in interventional clinical research within the Pakistani healthcare landscape.